DEFOPHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
DEFOPHARMA
Largest movements
- Receivables within one year +€8,331
up €8,331 (+24.9%), from €33,395 to €41,726
- Profit (loss) carried forward +€18,613
up €18,613 (+52.3%), from €35,570 to €54,183
- Debts after one year -€9,085
down €9,085 (-11.6%), from €78,451 to €69,366
of which Financial debts: -€9,085
- Tax, wage and social debts -€2,432
down €2,432 (-10.0%), from €24,254 to €21,822
of which Taxes: -€2,742
- Gross operating margin +€7,390
up €7,390 (+47.0%), from €15,719 to €23,109
- Taxes +€4,233
up €4,233, from -€2,087 to €2,146
- Financial charges +€617
up €617 (+35.6%), from €1,732 to €2,349
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €163,482 | €172,044 | +€8,562 | +5.2% |
| Fixed assets | 21/28 | €130,000 | €130,000 | = | 0.0% |
| Financial fixed assets | 28 | €130,000 | €130,000 | = | 0.0% |
| Current assets | 29/58 | €33,482 | €42,044 | +€8,562 | +25.6% |
| Amounts receivable within one year | 40/41 | €33,395 | €41,726 | +€8,331 | +24.9% |
| Trade receivables | 40 | €33,395 | €41,726 | +€8,331 | +24.9% |
| Cash at bank and in hand | 54/58 | €88 | €318 | +€230 | +262.6% |
| Total equity and liabilities | 10/49 | €163,482 | €172,044 | +€8,562 | +5.2% |
| Equity | 10/15 | €47,970 | €66,583 | +€18,613 | +38.8% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Profit (loss) carried forward | 14 | €35,570 | €54,183 | +€18,613 | +52.3% |
| Amounts payable | 17/49 | €115,513 | €105,461 | -€10,052 | -8.7% |
| Amounts payable after more than one year | 17 | €78,451 | €69,366 | -€9,085 | -11.6% |
| Financial debts | 170/4 | €65,835 | €56,750 | -€9,085 | -13.8% |
| Other amounts payable | 178/9 | €12,616 | €12,616 | = | 0.0% |
| Amounts payable within one year | 42/48 | €37,062 | €36,095 | -€967 | -2.6% |
| Current portion of amounts payable after more than one year | 42 | €8,170 | €9,085 | +€914 | +11.2% |
| Trade debts | 44 | €4,638 | €5,188 | +€551 | +11.9% |
| Suppliers | 440/4 | €4,638 | €5,188 | +€551 | +11.9% |
| Taxes, remuneration and social security | 45 | €24,254 | €21,822 | -€2,432 | -10.0% |
| Taxes | 450/3 | €9,343 | €6,601 | -€2,742 | -29.3% |
| Remuneration and social security | 454/9 | €14,911 | €15,221 | +€310 | +2.1% |
| Gross operating margin | 9900 | €15,719 | €23,109 | +€7,390 | +47.0% |
| Operating profit (loss) | 9901 | €15,719 | €23,109 | +€7,390 | +47.0% |
| Financial charges | 65/66B | €1,732 | €2,349 | +€617 | +35.6% |
| Recurring financial charges | 65 | €1,732 | €2,349 | +€617 | +35.6% |
| Profit (loss) for the period before taxes | 9903 | €13,987 | €20,760 | +€6,773 | +48.4% |
| Income taxes | 67/77 | -€2,087 | €2,146 | +€4,233 | |
| Profit (loss) for the period | 9904 | €16,074 | €18,613 | +€2,540 | +15.8% |
| Profit (loss) for the period to be appropriated | 9905 | €16,074 | €18,613 | +€2,540 | +15.8% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.